Difference in pain and functional outcome after arthroscopic debridement vs. debridement and biodegradable implanted balloon for irreparable rotator cuff tears.
- Conditions
- irreparable rupture of the muscles around the shouldermassive rotator cuff tears1004323710041297
- Registration Number
- NL-OMON50270
- Lead Sponsor
- Reinier Haga Orthopedisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 104
-Subject has an irreparable supra- and infraspinatus tendon tear confirmed by
ultrasound or MRI and is according to the Orthopaedic Surgeon a suitable
candidate for debridement.
-The symptoms of the subjects have been there for at least twelve months,
despite conservative treatment, including physiotherapy, subacromial
infiltration with corticosteroids or anti-inflammatory drugs.
-Subjects are older than 18 years.
-Subject is not able to complete the daily questionnaires in Dutch.
-Subject, in the opinion of the investigator, is not able to understand this
investigation and is not willing and able to perform all study procedures and
co-operate with investigational procedures.
-Subject has glenohumeral osteo-arthrosis grade 3 and 4 (KELLGREN and LAWRENCE
494-502).
-Subject has a total subscalpularis tendon tear.
-Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in
the last 5 years) or has a psychological disorder that could affect their
ability to complete subject reported questionnaires or be compliant with
follow-up requirements
-Subject was diagnosed and is taking prescription medications to treat a
muscular disorder that limits mobility due to severe stiffness and pain such as
fibromyalgia or polymyalgia.
- Subject has an active elevation of less than 60 degrees (pseudoparalysis).
-Subject has participated in a clinical investigation with an investigational
product (drug or device) in the last three months.
- Subject is allergic to the Balloon material
-Subject has a medical condition with less than 3 years of life expectancy.
.-Subject has refused voluntary, written informed consent to participate in
this randomized controlled trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Pain measured through a Numeric Rating Scale (NRS).</p><br>
- Secondary Outcome Measures
Name Time Method <p>-Time until the subjects receive a reversed shoulder prosthesis, if applicable<br /><br>- Functional outcome measured through Oxford Shoulder Score and Total Constant<br /><br>Score.<br /><br>- Radiological outcome measured through Ultrascound and X-ray<br /><br>-Complications</p><br>